Zurich Cantonal Bank
BMY.RT

Zurich Cantonal Bank’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Zurich Cantonal Bank’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-47,992
Closed -$33K – 2690
2020
Q4 		$33K Hold
47,992
– – ﹤0.01% 2528
2020
Q3 		$108K Buy
47,992
+21,274
+80% +$60.8K ﹤0.01% 1950
2020
Q2 		$96K Sell
26,718
-21,274
-44% -$76.8K ﹤0.01% 1968
2020
Q1 		$182K Sell
47,992
-2,297
-5% -$7.57K ﹤0.01% 1274
2019
Q4 		$151K Buy
+50,289
New +$131K ﹤0.01% 1491

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Zurich Cantonal Bank's BMY.RT Position: Q1 2021 in Review

Zurich Cantonal Bank sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 47,992 shares — an estimated $33K sold.

Zurich Cantonal Bank first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $182K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Zurich Cantonal Bank reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Zurich Cantonal Bank sold 47,992 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $33K.
  • Zurich Cantonal Bank first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Zurich Cantonal Bank's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $182K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Zurich Cantonal Bank's 13F filing for Q1 2021, filed 3 May 2021.